Enhanced Antibody Engineering for Development of Therapeutic Antibodies

2021-11-23T09:41:04-05:00March 23rd, 2021|Whitepapers|

Mouse monoclonal antibodies (mAbs) are highly attractive for manipulation for therapeutic applications as their manufacturing is relatively easy and well-established compared to mAbs derived from larger animal models. However, they also pose several challenges which limit their use as therapeutic agents.